Faculty
Oncology Division
Iskra Pusic, MD
Associate Professor
Department of Medicine
Oncology Division
Bone Marrow Transplantation & Leukemia
Clinical Interests
- Hematologic malignancies
- Hematopoietic stem cell transplantation
- Chronic graft-versus-host disease
Research Interests
- Chronic graft-versus-host disease
- Graft-versus-tumor effects
- Transplant biology
Contact
- 314-454-8306 (office)
- 314-454-7551 (fax)
- iskrapusic@wustl.edu
- Division of Oncology
Mail Stop 8007-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - 11th Floor Mid Campus Center (office)
Biosketch
| Education | |
|---|---|
| 1991-1997 | MD, University of Zagreb School of Medicine, Zagreb, Croatia |
| 1997-1998 | Obligatory Medical Traineeship, University Hospital Center “Rebro”, Zagreb, Croatia |
| Post-graduate Training | |
| 2001 | Post-doctoral Fellow/Research Associate, Division of Oncology, University of Nebraska Medical Center, Lied Transplant Center, Omaha, NE |
| 2001-2004 | Resident in Internal Medicine, Department of Internal Medicine, State University of New York - Downstate, Brooklyn, NY |
| 2004-2007 | Fellow in Hematology and Oncology, Division of Hematology and Oncology, State University of New York - Downstate, Brooklyn, NY |
| 2007-2008 | Fellow in Bone Marrow Transplantation and Leukemia, Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO |
| 2012-2015 | Master of Science in Clinical Investigation, Washington University School of Medicine, St. Louis, MO |
| Academic Positions & Employment | |
| 2008-2011 | Hospitalist, Department of Internal Medicine, Division of Hospital Medicine, Barnes-Jewish Hospital, St. Louis, MO |
| 2011-2013 | Instructor of Medicine, Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
| 2013-2019 | Assistant Professor, Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
| 2020-present | Associate Professor, Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
| University & Hospital Appointments & Committees | |
| 2014-present | Protocol Review and Monitoring Committee (PRMC) |
| 2021-present | Washington University School of Medicine Data and Safety Monitoring Board (DSMB) |
| 2021-present | Washington University School of Medicine, Goal Deployment Process Team for central line-associated bloodstream infections (CLABSI) reduction |
| Board Certification | |
| 2004 | Internal Medicine, American Board of Internal Medicine |
| 2008 | Medical Oncology, American Board of Internal Medicine |
| 2009, 2021 | Hematology, American Board of Internal Medicine |
| 2021 | Cardio-Oncology, International Cardio-Oncology Society |
| Honors & Awards | |
| 2007 | Chronic Graft-versus-Host Disease (GvHD) Workshop - Implementation of the National Institutes of Health (NIH) Consensus Criteria for Clinical Trials, NIH, Bethesda, MD |
| 2008 | American Society of Blood and Marrow Transplantation Travel Grant |
| 2009 | American Society of Blood and Marrow Transplantation Clinical Research Training Course |
| 2012-2015 | Institute of Clinical and Translational Sciences KL2 Career Development Award, Washington University School of Medicine, St. Louis, MO |
| 2018-2020 | American Cancer Society-Institutional Research Grant, St. Louis, MO |
| 2018-2020 | Clinical and Translational Research Funding Program Grant, Washington University Institute of Clinical and Translational Sciences, St. Louis, MO |
| Editorial Responsibilities | |
| 2019 | Abstract Reviewer, American Society of Hematology (ASH) Meeting |
| 2020 | Coordinating Abstract Reviewer, ASH meeting |
| 2021 | International Cardio-Oncology Society, Board Exam Development Committee Member |
| 2021 | Abstract Reviewer for American Society of Transplantation and Cellular Therapies (ASTCT) meeting, formerly ASBMT |
| 2021 | Faculty on International Cardio-Oncology Society board review course |
| National Scientific Panels | |
| 2019-present | National Comprehensive Cancer Network (NCCN), Disease-specific Guidelines Panel - Chronic Myeloid Leukemia |
| 2019-present | Committee on Practice Guidelines at American Society of Transplantation and Cellular Therapies (ASTCT) |
| 2020-present | State of Science Symposium, GvHD Committee, BMT Clinical Trials Network (CTN) |
| 2020-present | NIH Chronic GvHD Consensus Working Group, Section on GvHD Etiology and Prevention |
| 2020-present | International Cardio-Oncology Society, Scientific & Research Committee |
| Professional Societies & Organizations | |
| 2004-present | American Society of Transplantation and Cellular Therapies (ASTCT); previously ASBMT |
| 2004-present | American Society of Hematology |
| 2008-present | Center for International Blood and Marrow Transplant Research, GvHD Working Committee |
| 2009-present | Rare Diseases Clinical Research Network - Chronic GVHD Consortium |
| 2015-present | Clinical Trials Network |
| 2016-2018 | Association of Croatian American Professionals, Medicine and Health Sciences Section |
| 2018-present | Women Committee in American Society of Transplantation and Cellular Therapies |
| 2019-present | Survivorship Special Interest Group at ASTCT |
| 2020-present | International Cardio-Oncology Society |
